Players throughout the pharmaceutical supply chain are experiencing growing pressure to gain accreditation for handling the high-value, temperature-sensitive cargo, as having a certification become
For the 13th successful year running, SMi are expanding the scope of the conference to cover all aspects related to cold chain distribution, including how best to maintain GDP compliance i
The US FDA announced today that it has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio